Loading clinical trials...
Loading clinical trials...
Phase II Study of Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma
The study is aimed to evaluate efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.
Investigators designed this study of a re-irradiation with single radiosurgery or hypofractionated intensity modulated radiation therapy (IMRT) with or without temozolomide. Objective of the study is evaluating efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Istituto Clinico Humanitas
Rozzano, Milan, Italy
Start Date
May 27, 2015
Primary Completion Date
June 1, 2022
Completion Date
June 1, 2022
Last Updated
September 15, 2022
88
ACTUAL participants
IMRT with or without radiosensitive therapy
RADIATION
Radiosensitive therapy
DRUG
Lead Sponsor
Istituto Clinico Humanitas
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions